Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,226 | -95,304 | 68,271 | -41,276 | 41,798 |
| Depreciation Amortization | 2,486 | 10,253 | 5,615 | 14,489 | 13,132 |
| Income taxes - deferred | -6,334 | -19,152 | 3,556 | -4,000 | 69 |
| Accounts receivable | 2,471 | 3,452 | 3,054 | -10,050 | -8,440 |
| Accounts payable and accrued liabilities | 4,641 | -2,032 | 595 | -434 | -8,533 |
| Other Working Capital | -10,484 | -34,017 | -34,773 | -21,411 | -4,599 |
| Other Operating Activity | 2,121 | 54,084 | -29,656 | 81,583 | 50,866 |
| Operating Cash Flow | $-38,325 | $-82,716 | $16,662 | $18,901 | $84,293 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 38,598 | -16,803 | 38,004 | -36,057 | -30,101 |
| PPE Investments | 125 | -178 | -591 | -1,201 | -1,629 |
| Net Acquisitions | N/A | N/A | N/A | 628 | N/A |
| Purchase Sale Intangibles | N/A | -20,000 | -53,111 | N/A | N/A |
| Other Investing Activity | 0 | -20,000 | -53,111 | 0 | 0 |
| Investing Cash Flow | $38,723 | $-36,981 | $-15,698 | $-36,630 | $-31,730 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 143,750 | N/A | -277 | N/A |
| Debt Repayment | N/A | N/A | N/A | -1,225 | -9,029 |
| Common Stock Issued | 118 | 3,488 | 404 | 440 | 6,990 |
| Common Stock Repurchased | N/A | -27,637 | -22,361 | N/A | N/A |
| Other Financing Activity | -145 | -6,942 | -1,361 | -6,892 | -21,712 |
| Financing Cash Flow | $-27 | $112,659 | $-23,318 | $-7,954 | $-23,751 |
| Exchange Rate Effect | 78 | -201 | -297 | -166 | -3,508 |
| Beginning Cash Position | 9,325 | 16,564 | 39,215 | 65,064 | 39,760 |
| End Cash Position | 9,774 | 9,325 | 16,564 | 39,215 | 65,064 |
| Net Cash Flow | $449 | $-7,239 | $-22,651 | $-25,849 | $25,304 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,325 | -82,716 | 16,662 | 18,901 | 84,293 |
| Capital Expenditure | -29 | -178 | -591 | -1,201 | -1,629 |
| Free Cash Flow | -38,354 | -82,894 | 16,071 | 17,700 | 82,664 |